Clinical and molecular assessment of an onco-immune signature with prognostic significance in patients with colorectal cancer.

MLA

Ahluwalia, Pankaj, et al. “Clinical and Molecular Assessment of an Onco-Immune Signature with Prognostic Significance in Patients with Colorectal Cancer.” Cancer Medicine, vol. 11, no. 6, Mar. 2022, pp. 1573–86. EBSCOhost, https://doi.org/10.1002/cam4.4568.

APA

Ahluwalia, P., Mondal, A. K., Ahluwalia, M., Sahajpal, N. S., Jones, K., Jilani, Y., Gahlay, G. K., Barrett, A., Kota, V., Rojiani, A. M., & Kolhe, R. (2022). Clinical and molecular assessment of an onco-immune signature with prognostic significance in patients with colorectal cancer. Cancer Medicine, 11(6), 1573–1586. https://doi.org/10.1002/cam4.4568

Chicago

Ahluwalia, Pankaj, Ashis K Mondal, Meenakshi Ahluwalia, Nikhil S Sahajpal, Kimya Jones, Yasmeen Jilani, Gagandeep K Gahlay, et al. 2022. “Clinical and Molecular Assessment of an Onco-Immune Signature with Prognostic Significance in Patients with Colorectal Cancer.” Cancer Medicine 11 (6): 1573–86. doi:10.1002/cam4.4568.